Embecta Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Embecta Corp.
- Former names
- Berra Newco, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Parsippany
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- EMBC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001872789
- EIN
- 87-1583942
Board of directors
-
Carrie L. Anderson · DirectorSince 2023
-
Christopher R. Reidy · DirectorSince 2022
-
Claire Pomeroy · DirectorSince 2023
-
David Albritton · DirectorSince 2023
-
David F. Melcher · DirectorSince 2022
-
Devdatt Kurdikar · Director · President and CEOSince 2023
-
Karen Prange · DirectorSince 2023
-
Milton Mayo Morris · DirectorSince 2023
-
Robert J. Hombach · DirectorSince 2023
Chief executives
Devdatt Kurdikar
· President and CEO
Dates unknown
Director election results
Annual meeting of February 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.4%
-
98.1%
-
98.6%
-
99.5%
-
99.8%
Board connections
6 of this board's directors also sit on 10 other boards.
- via Karen Prange
- via Robert J. Hombach
- via Christopher R. Reidy
- via Claire Pomeroy
- via Robert J. Hombach
- via Milton Mayo Morris
- via Milton Mayo Morris
- via Karen Prange
- via Robert J. Hombach
- via Devdatt Kurdikar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $557,945
- 4 purchases by 4 insiders
- Sold, last 12 months
- $36,971
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Milton Mayo Morris Director | Open-market sale | −6,293 | $5.88 | $36,971 |
| Aug 12, 2026 | Elguicze Jacob Officer (SVP and CFO) | Open-market purchase | +20,000 | $4.67 | $93,360 |
| Aug 12, 2026 | Robert J. Hombach Director | Open-market purchase | +45,000 | $4.97 | $223,848 |
| Aug 12, 2026 | Mann Jeffrey Z Officer (Pres, Pharm Svc&Prod Mgmt, CLO) | Open-market purchase | +20,000 | $4.99 | $99,800 |
| Aug 12, 2026 | Devdatt Kurdikar Director, Officer (President and CEO) | Open-market purchase | +30,000 | $4.70 | $140,937 |
| Aug 9, 2026 | Casner Jean Officer (Chief Human Resources Officer) | Shares withheld for tax | −1,480 | $4.42 | $6,542 |
| Jun 1, 2026 | Roth Anthony M. Officer (VP, Chief Accounting Officer) | Grant or award | +30,000 | — | — |
| Feb 11, 2026 | Carrie L. Anderson Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Robert J. Hombach Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Milton Mayo Morris Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Karen Prange Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Claire Pomeroy Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Christopher R. Reidy Director | Grant or award | +22,841 | — | — |
| Nov 26, 2025 | Roth Anthony M. Officer (Chief Accounting Officer) | Grant or award | +32,817 | — | — |
| Nov 26, 2025 | Casner Jean Officer (Chief Human Resources Officer) | Grant or award | +38,783 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.